In order to do a good job in the production and supply of medical materials in short supply for the prevention and control of the current epidemic situation, Sichuan Province recently issued a notice to emergency headquarters, novel coronavirus, and made arrangements for ensuring supply from nine aspects, including supporting key production enterprises to increase production and supply.
On December 22nd, the reporter interviewed a number of pharmaceutical enterprises in Sichuan. "Full horsepower", "full load production" and "24-hour uninterrupted" are the workshop conditions of many pharmaceutical companies. They expand their production capacity by temporarily transforming production lines and speeding up the layout of new production lines, and do their best to meet the needs of consumers for scarce drugs.
Sichuan is a big province of medicine, which produces more drugs for preventing and treating COVID-19’s symptoms. On December 19th, the Department of Economic and Information Technology, the Department of Commerce, the Provincial Health and Health Commission and other six departments published the Recommended Catalogue of Local Varieties of Preventive and Therapeutic Drugs in COVID-19, Sichuan Province (First Edition), which recommended 17 local western medicine varieties and 117 local Chinese medicine varieties to the public, involving more than 40 Sichuan pharmaceutical enterprises.
For example, in order to relieve fever, headache, myalgia and other symptoms, the symptomatic western medicines made in Sichuan include Benoit tablets, paracetamol drops, children Benoit vitamin B1 granules, lysine aspirin for injection, ibuprofen sustained-release suspension and other products; In the catalogue, there are 7 enterprises that produce cough syrup for children and 6 enterprises that produce Xiaochaihu granules.
"Broaden the choice of consumers with the varieties of local drugs, which puts higher demands on the ability of pharmaceutical companies to ensure supply." Yang Jinmin, deputy general manager in charge of production of Good Doctor Pharmaceutical Group, said that the company has two factories in Mianyang City and Liangshan Prefecture, which used to produce 58 kinds of drugs every day. In the past few days, the production capacity has been concentrated on the production of more than 10 kinds of antiviral drugs, and more than 480 people have taken turns to work, and the machinery and equipment have been non-stop. "We have concentrated on deploying 16 general production lines and have transformed them into special production lines for antiviral drugs."
The reporter learned in the interview that some pharmaceutical companies are also facing challenges such as raw material supply and employment security. Our province clearly requires strengthening departmental coordination, provincial and municipal linkage, and actively helps key production and circulation enterprises with shortage of medical materials to coordinate and solve existing difficulties and problems; Encourage banking financial institutions to actively increase financial support, do their best to ensure water, electricity and other factors, and support enterprises to produce at full capacity. The relevant departments in Chengdu have set up special classes to enter key pharmaceutical enterprises to help solve the problems encountered in the production and operation of enterprises. (Reporter   Zhang Shoushuai   Tang zewen)